Parameter | Score |
---|---|
1. Scale | A |
2. Study Population | B |
3. Samples | A |
4. Measurand | A |
5. Pre-Analytical | B |
6. Replicate Analysis | B |
7. Steady State | C |
8. Outlier Analysis | C |
9. Normality | B |
10. Variance Homogeneity | A |
11. ANOVA | B |
12. CI | C |
13. No of Results | C |
14. Concentrations | A |
15. Total Score | C7,8,12,13 |
Comment |
Parameter | Score |
---|---|
Matrix | Serum |
Measurand | Neuron specific enolase |
Unit | ng / mL |
Overall Analytical Principle Method | Immunoassay; Not specified |
Number of Subjects | 40 |
Number of Subjects included in BV estimation | 40 |
Ethinicity | Unknown |
Age Mean / Median | 25.0 |
Age Min | |
Age Max | |
Age SD | |
Number of Males | |
Number of Females | |
State of Well Being |
Healthy (excl pregnant)
|
Diseases | |
Study Duration Length | 3 |
Study Duration Units | Week |
Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
Interval Units | Other |
Sampling Times | Start Time:
End Time: |
Number of Samples | 4 |
Average Number of Samples Used for BV Estimation | 4.0 |
Average Number of Replicates | 0.0 |
Estimates of CVi | 23.0 |
Calculated Confidence Intervals of CVi | Lower: 20.42, Upper: 26.33 |
Estimates of CVg | |
Calculated Confidence Intervals of CVg | Lower: 0.00, Upper: |
Analytical CV | 1.0 |
Calculated Confidence Intervals of Analytical CV | Lower: 0.74, Upper: 1.52 |
Measurand Mean | 14.2 |
Measurand Min | |
Measurand Max | |
Measurand SD |